MedPath

Self-help intervention to reduce psychological distress among university students in Indonesia

Not Applicable
Conditions
Psychological distress (symptoms of anxiety and depression)
Mental and Behavioural Disorders
Registration Number
ISRCTN15761598
Lead Sponsor
Ministry of Research, Technology and Higher Education of Republic Indonesia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
194
Inclusion Criteria

1. University students
2. Aged between 17-24 years old
3. Increased levels of psychological distress based on the Kessler psychological distress scale-10 items (K10; K10 =18)

Exclusion Criteria

1. Acute medical conditions that require immediate hospitalization.
2. Shows imminent suicide risk or self-harm or other life-threatening risk based on interview based on the question of imminent risk of suicide from Problem Management Plus (PM+) manual
3. Indication of severe cognitive impairment related to a mental, neurological or substance abuse based on PM+ observation checklist; and
4. Initiated, stopped, or significantly modified pharmacotherapy in the last eight weeks.
5. Initiated or stopped specialized psychological treatment (e.g., Cognitive Behavioural Therapy, psychoanalytic therapy) in the last eight weeks.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Psychological distress as measured by the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) total score. It will be administered at baseline, 1-week post-intervention, 3- (primary end point) and 6-month follow-up.
Secondary Outcome Measures
NameTimeMethod
Measured at baseline, 1-week post-intervention, 3- and 6-month follow-up <br>1. Symptoms of depression will be measured with Patient Health Questionnaire (PHQ-9) <br>2. Symptoms of anxiety will be measured by General Anxiety Disorder (GAD-7)<br>3. Perceived stress will be measured by Perceived Stress Scale (PSS) <br>4. General functioning measured by WHO Disability Assessment 2.0 (WHODAS 2.0) <br>5. Quality of life will be measured by EQ-5D-5L<br>6. Exposure to objective microstressors will be measured by the Mainz Inventory of Microstressors (MIMIS), which will be adapted for the current population<br>7. Self-identified problems measured using the PSYCHLOPS<br><br>Added 06/08/2024:<br>8. Cost-effectiveness from analysis of EQ-5D-5L and Client Service Receipt Inventory (CSRI)
© Copyright 2025. All Rights Reserved by MedPath